Detalhe da pesquisa
1.
Designer drugs: a medicinal chemistry perspective (II).
Ann N Y Acad Sci
; 1489(1): 48-77, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396701
2.
Synthesis and Characterization of the Selective, Reversible PKCß Inhibitor (9 S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9 H,18 H-5,21:12,17-dimethenodibenzo[ e,k]pyrrolo[3,4- h][1,4,13]oxadiazacyclohexadecine-18,20(19 H)-dione, Ruboxistaurin (LY333531).
ACS Chem Neurosci
; 10(1): 246-251, 2019 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30156829
3.
Caged Naloxone: Synthesis, Characterization, and Stability of 3- O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX).
ACS Chem Neurosci
; 9(3): 563-567, 2018 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29154536
4.
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198).
ACS Chem Neurosci
; 6(12): 1956-64, 2015 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26367173
5.
Synthesis and pharmacological evaluation of highly potent [Dmt1]DALDA analogs.
Adv Exp Med Biol
; 611: 473-4, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19400270
6.
Emergence and properties of spice and bath salts: a medicinal chemistry perspective.
Life Sci
; 97(1): 9-19, 2014 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24113072
7.
Synthesis of hemopressin peptides by classical solution phase fragment condensation.
Int J Pept
; 2012: 186034, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23227057
8.
Designer drugs: a medicinal chemistry perspective.
Ann N Y Acad Sci
; 1248: 18-38, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22092008